This announcement is a separate document:
京新药业：关于广东沙溪制药有限公司2021年度至2023年度盈利实现情况的专项审核报告
Jingxin Pharmaceutical: Special Audit Report on the Profit Achievement Status of Guangdong Shaxi Pharmaceutical Co., Ltd. from 2021 to 2023
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.